Document is current
Any future updates will be listed below
-
Authors
Märkl, Florian https://orcid.org/0000-0003-4285-0380
Schultheiß, Christoph https://orcid.org/0000-0001-9789-5776
Ali, Murtaza
Chen, Shih-Shih
Zintchenko, Marina
Egli, Lukas
Mietz, Juliane https://orcid.org/0009-0007-9359-2242
Chijioke, Obinna https://orcid.org/0000-0003-4247-5947
Paschold, Lisa https://orcid.org/0000-0003-0020-1315
Spajic, Sebastijan
Holtermann, Anne
Dörr, Janina https://orcid.org/0000-0001-9447-882X
Stock, Sophia
Zingg, Andreas
Läubli, Heinz https://orcid.org/0000-0002-8910-5620
Piseddu, Ignazio
Anz, David
Minden, Marcus Dühren-von
Zhang, Tianjiao
Nerreter, Thomas https://orcid.org/0000-0002-0493-1369
Hudecek, Michael https://orcid.org/0000-0002-2280-2202
Minguet, Susana https://orcid.org/0000-0001-8211-5538
Chiorazzi, Nicholas https://orcid.org/0000-0003-1023-6650
Kobold, Sebastian https://orcid.org/0000-0002-5612-4673
Binder, Mascha https://orcid.org/0000-0003-0663-3004
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (BI 1711/4-1)
- License Information
-
More Information
Article History
Received: 5 December 2023
Accepted: 22 January 2024
First Online: 2 February 2024
Competing interests
: M.D.M. discloses to be shareholder of AVA-Lifescience GmbH and inventor of patent application WO/2023/152204 (ANTIBODIES TARGETING THE B-CELL RECEPTOR OF CHRONIC LYMPHOCYTIC LEUKEMIA AND USES THEREOF). The use of the afore mentioned antibody sequences in CAR T cells is subject to the current patent application EP22186810.2 by M.D.M. and M.B. S.K., M.H. and T.N. are inventors of several patents in the field of cellular therapies. S.K. has received honoraria from BMS, GSK, Galapagos, Cymab, Novartis, Miltenyi Biomedicines and TCR2 Inc. S.K. has received license payments from TCR2 Inc and Carina Biotech. S.K. received research support from Arcus Biosciences, Plectonic GmbH, Tabby Therapeutics, Catalym GmbH and TCR2 Inc for work unrelated to this manuscript. All other authors disclose no potential conflicts of interest.
